Prevalence of Angle Closure in Caucasian Hyperopes

This study is currently recruiting participants.

Verified by Assaf-Harofeh Medical Center, January 2009

First Received: January 15, 2009 No Changes Posted

Sponsored by:	Assaf-Harofeh Medical Center
Information provided by:	Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:	NCT00823706

Purpose

The primary purpose of this study is to assess the prevalence of asymptomatic chronic angle closure in high risk Caucasian individuals, namely those with hyperopia. A secondary purpose is to assess whether specific demographic or ocular-anatomic parameters in this population are associated with a higher risk for angle closure.

Condition
Chronic Angle Closure Glaucoma

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Prevalence of Chronic Angle Closure in Caucasian Hyperopic Subjects

Resource links provided by NLM:

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma

U.S. FDA Resources

Further study details as provided by Assaf-Harofeh Medical Center:

Primary Outcome Measures:

prevalence of chronic angle closure in Caucasian hyperopes [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

relative risk for chronic angle closure measured for demographic and ocular-anatomic parameters [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment:	100
Study Start Date:	January 2009

Detailed Description:

Caucasian subjects aged > 40 years with hyperopia will undergo complete eye examination including subjective refraction and gonioscopy. In addition we will measure axial length, anterior chamber depth and lens thickness using ultrasound biometry.

Eligibility

Ages Eligible for Study:	40 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Caucasian subjects aged 40 years or more with hyperopia

Criteria

Inclusion Criteria:

Age greater than 40 years
Hyperopia greater then +1.00 D spherical equivalent

Exclusion Criteria:

Any identifiable eye disease or previous eye surgery that can affect the anatomy of the irido-corneal angle

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00823706

Contacts

Contact: yaniv barkana, md

97289779358

yanivbarkana@gmail.com

Locations

Israel
Assaf Harofe Medical Center Ophthalmology Department	Recruiting
Zerifin, Israel, 70300
Contact: Yaniv Barkana yanivbarkana@gmail.com

Sponsors and Collaborators

Assaf-Harofeh Medical Center

More Information

No publications provided

Responsible Party:	Assaf-Harofeh Medical Center, Department of Ophthalmology ( Yaniv Barkana, MD )
Study ID Numbers:	122/08
Study First Received:	January 15, 2009
Last Updated:	January 15, 2009
ClinicalTrials.gov Identifier:	NCT00823706 History of Changes
Health Authority:	Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:

chronic angle closure hyperopia

Study placed in the following topic categories:

Hyperopia
Glaucoma
Eye Diseases

Glaucoma, Angle-Closure
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Glaucoma
Eye Diseases
Glaucoma, Angle-Closure
Ocular Hypertension

ClinicalTrials.gov processed this record on September 01, 2009